Several interesting recent articles in PLoS Neglected Diseases:

Research Agenda for schisto

A reply to this Research Agenda warning against complacency with PZQ

The exciting identification of inhibitors of thioredoxin/glutathione reductase (TGR) as leads in schisto chemotherapy

This last paper comes from the same group who recently published an extremely important Nature Medicine paper on the identification of oxadiazoles for the treatment of schisto.

There was also an important publication in Nature from a group including Novartis on the identification of new compounds for the treatment of drug-resistant nematodes, especially important for the treatment of livestock infections.

A recent article in PLoS ND highlighting this essential resource for all those working (experimentally, biologically) in the schisto field.

 Excellent summary of the bio and use of praziquantel just published, including possible replacements.